Fujifilm to Buy Merck Units to Expand in Biologic Drugs

Fujifilm Holdings Corp. will buy two units of Merck & Co. that make biopharmaceuticals as it targets growth in the health-care industry to make up for declining sales in cameras and film.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.